| | 
Part, Chapter, Paragraph
1 -, 1 | Grant Agreement n. 2005115) (ii) produced through a 3-year
2 -, 1 | the Report development; ii) with the participation
3 -, 1 | sections: (i) Introduction; (ii) Data sources; (iii) Data
4 I, 2. 1 | i) higher productivity; (ii) higher labour supply;(iii)
5 II | PART II – HEALTH CONDITIONS~
6 II, 5. 3. 2 | com.fr/~ ~EUROCHIP I and II: The EUROCHIP project is
7 II, 5. 3. 2 | puDeliverable01.php~ ~MOSES II: The European Society for
8 II, 5. 3. 9 | Europe Survey (MOSES). Phase II. htt 1 (document online,
9 II, 5. 4. 2 | m2~14~ ~HES/HIS Registry~II Epidemiology of diabetes~ ~ ~
10 II, 5. 4. 2 | Countries with~recent data~II Epidemiology of diabetes~ ~
11 II, 5. 4. 8 | Revealing the cost of Type II diabetes in Europe. Diabetologia,
12 II, 5. 5.Int | the field of employment; (ii) Actions under the European
13 II, 5. 5.Int | security policy, the DAPHNE II programme combats violence
14 II, 5. 5. 3 | established~ by 24 months~ II 120 months (no AED; First
15 II, 5. 5. 3 | unprovoked seizure (6 months)~ II 60 months (taxi 120; Must
16 II, 5. 5. 3 | years~Estonia I 24 months -~ II - Prohibited~Finland I 12
17 II, 5. 5. 3 | months)~ Myoclonias (dose)~ II - Prohibited~France I 12
18 II, 5. 5. 3 | Seizures only on awakening~ II 24-60 months No seizures
19 II, 5. 5. 3 | Treatment stop (ban 3 months)~ II 60 months (no AED) First
20 II, 5. 5. 3 | year~Italy I 24 months -~ II - Prohibited~Netherlands
21 II, 5. 5. 3 | stop/change (ban 3 months)~ II 60 months (no AED; Untreated
22 II, 5. 5. 3 | particular~ circumstances~ II 120 months (taxi) -~Sweden
23 II, 5. 5. 3 | Single unprovoked seizure~ II 60 months (taxi) -~Switzerland
24 II, 5. 5. 3 | established~ by 3 years~ II 120 months (no AED) Medical
25 II, 5. 5. 3 | Non commercial driving; II = Commercial driving;~AED =
26 II, 5. 5. 3 | health services and society, ii) the cost of PD markedly
27 II, 5. 5. 3 | or financial assistance; (ii) living as a couple in the
28 II, 5. 6. 6 | psychiatric illness: the Whitehall II Study. Soc Sci Med 40:189-
29 II, 5. 8. 3 | suggested COPD GOLD stage II was 10.1% overall, 11.8%
30 II, 5. 8. 3 | of gender, and at stage II or higher at 10.7%. A doctor
31 II, 5. 8. 3 | respectively for stage I, II and III of the diseases.~ ~
32 II, 5. 8. 3(27)| FEV1 80% predicted~Stage II:~Moderate FEV1/FVC <0.70~
33 II, 5. 8. 4 | 1% for GOLD stages I and II+, respectively (De Marco
34 II, 5. 9. 2 | administered questionnaire. Phase II of ISAAC (in a large number
35 II, 5. 9. 2 | rhinitic symptoms. In stage II, in a smaller random sample
36 II, 5. 9. 2 | challenge were performed. ECRHS II is a nine year follow-up
37 II, 5. 9. 3 | Asthma ever in ECHRS phase II and ISAAC phase I by country.~ ~
38 II, 5. 9. 4 | Dermatophagoides pteronyssinus; (ii) timothy grass; (iii) cat; (
39 II, 5. 9. 4 | cross-sectional study (SIDRIA II study, (Migliore et al,
40 II, 5. 11. 6 | skin disease is very common ii) some skin diseases such
41 II, 5. 12. 4 | France, during World War II, when both alcohol consumption
42 II, 5. 14. 3 | International Collaborative II studies – experience difficulty
43 II, 6. 3. 3 | declined after World War II thanks to the widespread
44 II, 7. 5 | the health policy agenda; (ii) to develop injury surveillance
45 II, 8. 2. 1 | the Final Report of Pomona II will provide detailed information
46 II, 9. 2. 5 | adequate sanitation~· RPG II: ensure protection from
47 II, 9. 4. 5 | or financial assistance; (ii) living as a couple in the
48 III, 10. 1. 3 | alcohol and other problems. II: The intergenerational effects
49 III, 10. 2. 1 | the general population; (ii) problem drug use; (iii)
50 III, 10. 2. 1 | child health policies; (ii) to develop and implement
51 III, 10. 2. 1 | chronic diseases, such as type II diabetes and hypertension
52 III, 10. 2. 1 | be added to foods. Annex II is a list of the sources
53 III, 10. 2. 1 | the forms listed in Annex II, may be added to foods.~ ~
54 III, 10. 2. 1 | informed choices. Annex II of this Directive is a list
55 III, 10. 2. 1 | minerals not listed in Annex II has been prohibited since
56 III, 10. 3. 1 | skin phototype (type I and II), a large number of naevi
57 III, 10. 3. 2 | number of major “Seveso II accidents” (see below) reported
58 III, 10. 3. 2 | enforcement of the Seveso II directive on major accident
59 III, 10. 3. 2 | by the EEA.~ ~The Seveso II Directive, adopted in 1996
60 III, 10. 3. 2 | Seveso in 1976. The Seveso II Directive was broader in
61 III, 10. 4. 2 | e.g. withdrawal or recall; (ii) information notifications,
62 III, 10. 4. 2 | withdrawal or recall); (ii) information notifications,
63 III, 10. 4. 2 | Regulation 396/2005:~· Annex II deals with MRLs established
64 III, 10. 4. 2 | the latest draft Annexes II and III which specify the
65 III, 10. 4. 2 | feed and food.~ ~Chapter II of the Regulation seeks
66 IV, 11. 6. 2 | higher income or Category II patients), Luxembourg and
67 IV, 11. 6. 2 | Finland, Ireland (Category II patients) and Belgium (Thomson
68 IV, 11. 6. 5 | G (2005): Mental health II: Balancing institutional
69 IV, 12. 5 | list that will serve Part II - Health policies and action
70 IV, 12. 6 | patients’ organizations; (ii) organizations representing
71 IV, 12. 10 | Cocaine~Use in Ireland: II published in march 2007~
72 IV, 12. 10 | dealing with (i) children, (ii) older people and (iii)
73 IV, 13. 7. 3 | research institutions; (ii) competitiveness in top
|
|
| |
